UBS warns Lululemon’s US sales may stay weak into 2026

UBS said Lululemon's US sales weakness could persist through 2026 despite a CEO reset, citing its survey showing tough trends. The bank kept a Neutral rating and $206 target, saying the company may need at least a year to restore sustainable growth. US revenue fell 2% in Q3 amid weak demand, tariffs and rising competition.